3-year follow-up of the NIMH MTA study.

OBJECTIVE In the intent-to-treat analysis of the Multimodal Treatment Study of Children With ADHD (MTA), the effects of medication management (MedMgt), behavior therapy (Beh), their combination (Comb), and usual community care (CC) differed at 14 and 24 months due to superiority of treatments that used the MTA medication algorithm (Comb+MedMgt) over those that did not (Beh+CC). This report examines 36-month outcomes, 2 years after treatment by the study ended. METHOD For primary outcome measures (attention-deficit/hyperactivity disorder [ADHD] and oppositional defiant disorder [ODD] symptoms, social skills, reading scores, impairment, and diagnostic status), mixed-effects regression models and orthogonal contrasts examined 36-month outcomes. RESULTS At 3 years, 485 of the original 579 subjects (83.8%) participated in the follow-up, now at ages 10 to 13 years, (mean 11.9 years). In contrast to the significant advantage of MedMgt+Comb over Beh+CC for ADHD symptoms at 14 and 24 months, treatment groups did not differ significantly on any measure at 36 months. The percentage of children taking medication >50% of the time changed between 14 and 36 months across the initial treatment groups: Beh significantly increased (14% to 45%), MedMed+Comb significantly decreased (91% to 71%), and CC remained constant (60%-62%). Regardless of their treatment use changes, all of the groups showed symptom improvement over baseline. Notably, initial symptom severity, sex (male), comorbidity, public assistance, and parental psychopathology (ADHD) did not moderate children's 36-month treatment responses, but these factors predicted worse outcomes over 36 months, regardless of original treatment assignment. CONCLUSIONS By 36 months, the earlier advantage of having had 14 months of the medication algorithm was no longer apparent, possibly due to age-related decline in ADHD symptoms, changes in medication management intensity, starting or stopping medications altogether, or other factors not yet evaluated.

[1]  B. Chow,et al.  Pediatric psychotropic medication compliance: a literature review and research-based suggestions for improving treatment compliance. , 2001, Journal of child and adolescent psychopharmacology.

[2]  D. Shaffer,et al.  NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[3]  S. Faraone,et al.  Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. , 2000, The American journal of psychiatry.

[4]  G. Weiss,et al.  Studies on the Hyperactive Child: VIII. Five-Year Follow-up , 1971 .

[5]  R. Schachar,et al.  Parental Knowledge of Attention-Deficit Hyperactivity Disorder and Opinions of Treatment Options: Impact on Enrolment and Adherence to a 12-Month Treatment Trial , 1999, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[6]  J. Swanson,et al.  NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution , 1997 .

[7]  N. Lambert,et al.  Persistence of hyperactivity symptoms from childhood to adolescence and associated outcomes. , 1987, The American journal of orthopsychiatry.

[8]  J. Severe,et al.  Reliability of the services for children and adolescents-parent interview. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[9]  R. Barkley,et al.  The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[10]  D. Mennin,et al.  A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. , 1996, Archives of general psychiatry.

[11]  G. Weiss,et al.  Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[12]  D. Cox,et al.  Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[13]  L. Hechtman.  Adolescent outcome of hyperactive children treated with stimulants in childhood: a review. , 1985, Psychopharmacology bulletin.

[14]  J. Swanson,et al.  National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. , 2004, Pediatrics.

[15]  J. Swanson,et al.  Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[16]  J. Swanson,et al.  National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder. , 2004, Pediatrics.

[17]  D. R. Smith,et al.  CHAPTER 6 – Wechsler Individual Achievement Test , 2001 .

[18]  M. Reiff.  Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD , 2001 .

[19]  M. Olfson,et al.  Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder. , 2005, Archives of pediatrics & adolescent medicine.

[20]  D. Thiruchelvam,et al.  Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[21]  Elizabeth B. Owens,et al.  Which treatment for whom for ADHD? Moderators of treatment response in the MTA. , 2003, Journal of consulting and clinical psychology.

[22]  H. Kraemer,et al.  ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[23]  S. Mannuzza,et al.  Hyperactive boys almost grown up. I. Psychiatric status. , 1985, Archives of general psychiatry.

[24]  J. Swanson,et al.  The services for children and adolescents-parent interview: development and performance characteristics. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[25]  Robert D. Gibbons,et al.  Estimating the Efficacy of Receiving Treatment in Randomized Clinical Trials with Noncompliance , 2001, Health Services and Outcomes Research Methodology.

[26]  M. Olfson,et al.  National trends in the treatment of attention deficit hyperactivity disorder. , 2003, The American journal of psychiatry.

[27]  A. Schell,et al.  A prospective study of delinquency in 110 adolescent boys with attention deficit disorder and 88 normal adolescent boys. , 1982, The American journal of psychiatry.

[28]  Stephen P. Hinshaw,et al.  A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. , 1999, Archives of general psychiatry.

[29]  L. Bickman,et al.  Child & adolescent psychiatry: the "clock-setting" cure: how children's symptoms might improve after ineffective treatment. , 2004, Psychiatric services.

[30]  D. Shaffer,et al.  The Columbia Impairment Scale (CIS): Pilot findings on a measure of global impairment for children and adolescents. , 1993 .

[31]  H. Kraemer,et al.  Multimodal treatment of ADHD in the MTA: an alternative outcome analysis. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[32]  Elizabeth B. Owens,et al.  Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.

[33]  J. Swanson.  Compliance with Stimulants for Attention-Deficit/Hyperactivity Disorder , 2003, CNS drugs.

[34]  R. Schachar,et al.  Stimulant treatment over five years: adherence, effectiveness, and adverse effects. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[35]  Kimberly Hoagwood,et al.  Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.